Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 350

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 19
Chunk 350
---
 basis of a CAPM model of the share price using a Monte Carlo approach;

• Adjustment of the estimation by applying expected turnover rates.

Expenses were € 119

BSA

Until 2017, the Company issued BSAs to members of the Supervisory Board and certain consultants. Following the AMF's position dated June 5, 2018, the Company has decided not to issue any further BSAs other than at market conditions to Supervisory Board members.

Details of BSA

                                          BSA 2013             BSA 2014             BSA 2015-1           BSA 2015-2           BSA 2017            
  Date of grant (Board of directors)      July 17, 2013        July 16, 2014        April 27, 2015       July 1, 2015         September 20, 2017  
  Vesting period (years)                  2 years              2 years              2 years              2 years              2 years             
  Plan expiration date                    July 17, 2023        July 16, 2024        April 26, 2025       June 30, 2025        September 20, 2027  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Number of BSA granted                                                                                                                           
  Share entitlement per BSA               1                    1                    1                    1                    1                   
  Exercise price                          € 2.36               € 8.65               € 9.59               € 14.05              € 11.00             
  Valuation method used                   Black & Scholes      Black & Scholes      Black & Scholes      Black & Scholes      Black & Scholes     
  Grant date share fair value             € 2.45               € 6.85               € 13.65              € 13.64              € 10.41             
  Expected volatility                     31.83                46.72                54.08                47.83                61.74               
  Average life of BSA                     5.5 years            5.5 years            5.5 years            5.5 years            6 years             
  Risk-free interest rate                 2.42                 1.00                 0.25                 0.25                 0.20                
  Expected dividends